Antibody Titers of Two Dose Intradermal Pre-exposure Rabies Prophylaxis Regimen in Children with No Known Immunodeficiency Versus Children Exposed to Immunosuppressant Therapy
Not Applicable
- Conditions
- Health Condition 1: M089- Juvenile arthritis, unspecified
- Registration Number
- CTRI/2022/10/046777
- Lead Sponsor
- Department Of Pediatrics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children and adolescents aged 5-18 years
Exclusion Criteria
1. History of receipt of any rabies vaccine.
2. Previous severe allergic reaction to any of the vaccine components.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method If mean antibody titers (IU/ml) after two dose pre-exposure rabies prophylaxis are comparable in children with no known immunodeficiency versus children exposed to immunosuppressant therapyTimepoint: At day 0, 28 and 90
- Secondary Outcome Measures
Name Time Method Adverse effect profile after two dose intradermal pre-exposure rabies prophylaxisTimepoint: At day 0 and 7